• 1. Excimer–monomer switch: a reaction-based approach for selective detection of fluoride?
  Qiao Song,Angela Bamesberger,Lingyun Yang,Haley Houtwed,Haishi Cao Analyst, 2014,139, 3588-3592
• 2. Establishing new scaling relations on two-dimensional MXenes for CO2 electroreduction?
  Albertus D. Handoko,Khoong Hong Khoo,Teck Leong Tan,Hongmei Jin,Zhi Wei Seh J. Mater. Chem. A, 2018,6, 21885-21890
• 3. Excellent energy storage performance in NaNbO3-based relaxor antiferroeic ceramics under a low electric field
  XuxinCheng,XiaomingChen,PengyuanFan
• 4. Evolution of cellulose into flexible conductive green electronics: a smart strategy to fabricate sustainable electrodes for supercapacitors
  Tengfei Yu,Yuehan Wu,Wei Li,Bin Li RSC Adv., 2014,4, 34134-34143
• 5. Exclusive self-aligned β-phase PVDF films with abnormal piezoelectric coefficient prepared via phase inversion?
  N. Soin,D. Boyer,K. Prashanthi,S. Sharma,A. A. Narasimulu,J. Luo,T. H. Shah,E. Siores,T. Thundat Chem. Commun., 2015,51, 8257-8260

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Amino acids, peptides, and analogues Amino acids and derivatives

Comprehensive Overview of D-Norvaline, N-(1-oxobutyl)- (CAS No. 528894-37-3): Properties, Applications, and Industry Insights

In the realm of specialized organic compounds, D-Norvaline, N-(1-oxobutyl)- (CAS No. 528894-37-3) stands out as a molecule of significant interest due to its unique structural and functional attributes. This compound, often referred to in scientific literature as N-Butyryl-D-norvaline, is a derivative of the non-proteinogenic amino acid D-Norvaline. Its molecular formula, C9H17NO3, and distinct chiral configuration make it a valuable intermediate in pharmaceutical research, peptide synthesis, and biochemical studies. The growing demand for enantiomerically pure compounds in drug development has further amplified the relevance of D-Norvaline, N-(1-oxobutyl)- in modern chemistry.

The synthesis and characterization of D-Norvaline, N-(1-oxobutyl)- involve advanced techniques such as asymmetric catalysis and chromatography. Researchers are increasingly focusing on its role in modulating enzyme activity and its potential as a building block for bioactive peptides. A trending topic in this context is the exploration of D-amino acid derivatives in neurodegenerative disease research, where compounds like N-Butyryl-D-norvaline are investigated for their ability to influence protein aggregation pathways. This aligns with the surge in Google searches for "D-amino acids in brain health" and "peptide therapeutics for Alzheimer's," highlighting the public's interest in cutting-edge medical applications.

From an industrial perspective, CAS No. 528894-37-3 is gaining traction in the nutraceutical sector, particularly in formulations targeting metabolic health. The compound's structural similarity to naturally occurring metabolites has spurred investigations into its effects on cellular energy regulation—a hot topic tied to popular search queries like "mitochondrial boosters" and "amino acid-based supplements." Manufacturers are also optimizing scalable production methods for D-Norvaline, N-(1-oxobutyl)- to meet the needs of high-throughput screening platforms in drug discovery.

Quality control and analytical profiling are critical for N-(1-oxobutyl)-D-norvaline, with HPLC-MS and NMR being the gold standards for purity verification. Recent discussions in academic forums emphasize the importance of isotopic labeling (e.g., ¹³C or ¹⁵N variants) for tracing studies, responding to the rising search volume for "labeled compounds in pharmacokinetics." Furthermore, the compound's stability under various pH conditions makes it a candidate for oral delivery systems—a key area in pharmaceutical innovation.

Environmental and regulatory considerations for 528894-37-3 are equally noteworthy. As sustainability becomes a priority, green chemistry approaches for synthesizing D-Norvaline derivatives are being explored, coinciding with search trends like "eco-friendly peptide synthesis." The compound's biodegradability profile and low ecotoxicity align with the global push for safer chemical alternatives, making it a subject of interest in ESG (Environmental, Social, and Governance) reports for life science companies.

In conclusion, D-Norvaline, N-(1-oxobutyl)- exemplifies the convergence of academic research and industrial application. Its versatility addresses multiple contemporary themes—from precision medicine to sustainable manufacturing—making it a compound worthy of attention in both scientific literature and market analyses. For researchers and industry professionals, staying updated on the latest developments around CAS No. 528894-37-3 is essential to leverage its full potential in tomorrow's innovations.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)